Live Breaking News & Updates on Harrow Health Daily

Stay updated with breaking news from Harrow health daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Harrow Health, Inc. (NASDAQ:HROW) Major Shareholder Opaleye Management Inc. Buys 29,400 Shares

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) major shareholder Opaleye Management Inc. purchased 29,400 shares of Harrow Health stock in a transaction dated Friday, April 19th. The shares were acquired at an average cost of $10.56 per share, for a total transaction of $310,464.00. Following the transaction, the insider now directly owns 3,775,000 shares […] ....

Craig-hallum , Institutional-trading-of-harrow-health , Eton-pharmaceuticals-inc , Harrow-health , Envestnet-asset-management-inc , Surface-ophthalmics-inc , Securities-exchange-commission , Nasdaq , Wasatch-advisors-inc , Opaleye-management-inc , Harrow-health-inc , Prelude-capital-management

Harrow Health, Inc. (NASDAQ:HROW) CEO Buys $104,310.00 in Stock

Harrow Health, Inc. (NASDAQ:HROW – Get Free Report) CEO Mark L. Baum acquired 9,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $11.59 per share, for a total transaction of $104,310.00. Following the completion of the acquisition, the chief executive officer now […] ....

Markl-baum , Surface-ophthalmics-inc , Rice-hall-james-associates , Harrow-health-company-profile , Jump-financial , Stifel-financial-corp , Harrow-health , Kennedy-capital-management , Pharmaceuticals-inc , Nasdaq , News-ratings-for-harrow-health-daily

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)

Harrow Health, Inc. Expected to Post Q1 2024 Earnings of ($0.25) Per Share (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Markl-baum , Harrow-health-trading , Institutional-trading-of-harrow-health , Blackrock-inc , Vanguard-group-inc , Pharmaceuticals-inc , Harrow-health , Opaleye-management-inc , Morgan-stanley , Insider-activity-at-harrow-health , Securities-exchange-commission

Harrow Health, Inc. (NASDAQ:HROW) Expected to Earn Q1 2024 Earnings of ($0.25) Per Share

Harrow Health, Inc. (NASDAQ:HROW – Free Report) – Investment analysts at B. Riley issued their Q1 2024 earnings per share estimates for shares of Harrow Health in a research note issued to investors on Thursday, March 21st. B. Riley analyst M. Mamtani forecasts that the company will post earnings of ($0.25) per share for the […] ....

Eton-pharmaceuticals-inc , Goldman-sachs-group-inc , Harrow-health , Nasdaq , Nuveen-asset-management , Harrow-health-stock , Barclays-plc , Surface-ophthalmics-inc , Pricet-rowe-associates-inc , News-ratings-for-harrow-health-daily , Vanguard-group-inc

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)

Paradigm Capital Management Inc. NY Acquires New Position in Harrow Health, Inc. (NASDAQ:HROW)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Harrow-health-inc , Quarter-for-harrow-health , News-ratings-for-harrow-health-daily , Pharmaceuticals-inc , Surface-ophthalmics-inc , Harrow-health , Nasdaq , Prelude-capital-management , Eton-pharmaceuticals-inc , Harrow-health-trading , Wasatch-advisors-inc